Insulet (PODD) Reports In-Line Q1 EPS

Insulet (NASDAQ: PODD) reported Q1 EPS of ($0.19), inline with the analyst estimate. Revenue for the quarter came in at $81.2 million versus the consensus estimate of $79.06 million.

GUIDANCE:

Insulet sees Q2 2016 revenue of $81-84 million, versus the consensus of $82.3 million.

• For the year ending December 31, 2016, the Company is reaffirming its revenue guidance of $330 to $350 million

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c